Next, we wished to assess the influence of CTV-1 priming and IL-2 (100 U/ml) activation on the cytotoxicity of NK cells isolated from thawed PBMC preparations derived from patients with prostate cancer against PC3 and K562 cells. The gene discussed is IL2; the disease is prostate cancer.